Funds and ETFs ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-04-26 pm EDT 5-day change 1st Jan Change
218.1 USD +18.89% Intraday chart for ResMed, Inc. +21.92% +26.76%

ETFs positioned on ResMed, Inc.

Name Weight AuM 1st Jan change Investor Rating
1.09% 18 M€ +3.79% -
1.03% 16 M€ -8.49%
0.73% 204 M€ +10.54%
0.43% 8 M€ +2.44%
0.43% 40 M€ -.--%
0.38% 9 M€ -.--% -
0.38% 2 M€ +6.77%
0.33% 105 M€ +6.17%
0.29% 5 M€ -72.95% -
0.21% 52 M€ +6.98%
0.20% 10 M€ +5.96%
0.20% 267 M€ +5.99%
0.18% 219 M€ +17.17% -
0.18% 1,448 M€ -.--% -
0.18% 2,510 M€ +12.00%
0.16% 736 M€ +6.09%
0.16% 9 M€ +2.75% -
0.16% 36 M€ -.--%
0.16% 4 M€ -.--% -
0.13% 276 M€ +11.40% -
0.12% 277 M€ -.--% -
0.12% 194 M€ +7.48% -
0.12% 441 M€ +10.26%
0.11% 8 M€ +3.41% -
0.11% 33 M€ +0.25% -
0.11% 18 M€ +3.41% -
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (50.4%); - masks (37.9%); - software as a service (11.7%). At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia. The United States accounts for 61.4% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
218.1 USD
Average target price
212.4 USD
Spread / Average Target
-2.61%
Consensus
  1. Stock Market
  2. Equities
  3. RMD Stock
  4. Funds and ETFs ResMed, Inc.